Upfront radioimmunotherapy represents an effective and safe therapeutic option in cutaneous B-cell non-Hodgkin lymphoma

Ann Hematol. 2012 Jan;91(1):129-30. doi: 10.1007/s00277-011-1216-1. Epub 2011 Mar 25.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Lymphoma, B-Cell / immunology*
  • Lymphoma, B-Cell / pathology
  • Lymphoma, B-Cell / radiotherapy*
  • Radioimmunotherapy / methods*
  • Treatment Outcome